AlphaFold Won the Nobel Prize for Predicting Proteins. Now the Same Team Is Designing the Drugs.

Isomorphic Labs raised $2.1B in May 2026 to push its first AI-designed drugs into clinical trials. The DeepMind spinout's IsoDDE engine doesn't just predict protein shapes — it designs the molecules that bind to them. The first AI-designed cancer drug is expected in Phase 1 trials by end of 2026.